Development of a new drug for progeria syndrome; Past, Present and Future
Open Access
- 8 June 2020
- journal article
- Published by Peertechz Publications Private Limited in Archive of Gerontology and Geriatrics Research
- Vol. 5 (1), 022-025
- https://doi.org/10.17352/aggr.000020
Abstract
Eleven early maize (Zea mays) genotypes were evaluated for their yield and yield attributing traits at the research block of Regional Agriculture Research Station (RARS) Lumle, Kaski, Nepal during kharif season of 2016.Keywords
This publication has 25 references indexed in Scilit:
- Farnesyltransferase inhibitor treatment restores chromosome territory positions and active chromosome dynamics in Hutchinson-Gilford progeria syndrome cellsGenome Biology, 2011
- Phenotype and Course of Hutchinson–Gilford Progeria SyndromeThe New England Journal of Medicine, 2008
- Hutchinson–Gilford progeria syndrome: Review of the phenotypeAmerican Journal of Medical Genetics Part A, 2006
- Nuclear lamins, diseases and agingCurrent Opinion in Cell Biology, 2006
- A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of ProgeriaScience, 2006
- Novel progerin-interactive partner proteins hnRNP E1, EGF, Mel 18, and UBC9 interact with lamin A/CBiochemical and Biophysical Research Communications, 2005
- Lamin A Truncation in Hutchinson-Gilford ProgeriaScience, 2003
- Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndromeNature, 2003
- Lethal neonatal Hutchinson-Gilford progeria syndromeAmerican Journal of Medical Genetics, 1999
- Progressive Early Dermatologic Changes in Hutchinson-Gilford Progeria SyndromePediatric Dermatology, 1991